Satnam Surae, chief product officer, Aigenpulse examines how automation can benefit the pharma industry when it comes to data processing and analytics.
Pari Sanghavi, senior director, life sciences supply chain and manufacturing at Cognizant and Jim Lehane, global leader business development at Zenith discuss how manufacturing must change following Covid-19.
Gero Lustig, global business manager Pharma and Life Sciences at ABB explains how using a digital twin of existing machines can determine how best to implement shop floor integration prior to installation.
Rod Schregardus, supply chain technology specialist at Access Group, discusses the role of advanced planning and scheduling (APS) systems in pharmaceuticals manufacturing.
Justin Schroeder, vice president for global programme management at PCI Pharma Services, looks at how to support the delivery of biologics through automated inspection systems.
Jonathan Wilkins, marketing director of obsolete industrial parts supplier EU Automation, explains how biopharmaceutical plants can benefit from automation.
Lab automation has come a long way since the days of industrial robots, with new advancements increasing efficiency between systems and workers. Peter Harris, HighRes Biosolutions, discusses how far the sector has moved and what the future holds.
Nick Lynch, consultant at The Pistoia Alliance discusses how technology, including artificial intelligence (AI), can help automate the lab and accelerate outcomes.
Transparency Market Research has predicted that the global pharmaceutical robots market is set to witness high adoption of regional expansion, new product development and merger & acquisition as key business strategies, bagging $250.46m by 2026
